Ultragenyx Pharmaceutical Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor


Ultragenyx Pharmaceutical Inc. Website Screenshot

http://www.ultragenyx.com

Ultragenyx Pharmaceutical Inc. Company Intro

Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.

Industry

Healthcare

Ultragenyx Pharmaceutical Inc. Headquaters

60 Leveroni Court
Novato,94949
United States


Ultragenyx Pharmaceutical Inc. Share price

14 Sep 2022 10:06 GMT

$47.63

-1.15 (-2.36 %)


Ultragenyx Pharmaceutical Inc. Market cap

$3.123 B


WMC RANKING

2022

Ultragenyx Pharmaceutical Inc. # 49

Biotechnology

Latest Ultragenyx Pharmaceutical Inc. News

News 27 Sep 2022

Ornithine-Transcarbamylase Deficiency Market Size And ...

PhaseRx Inc; Ultragenyx Pharmaceutical Inc; Promethera Biosciences SA; Unicyte AG; Lucane Pharma SA; Translate Bio Inc; Selecta Biosciences Inc. Market...

News 26 Sep 2022

Surprising Analyst 12-Month Target For IWR

iShares Russell Mid-Cap ETF, IWR, $63.62 ; Ginkgo Bioworks Holdings Inc, DNA, $2.80 ; Ultragenyx Pharmaceutical Inc, RARE, $41.50 ; Upstart Holdings Inc, UPST...

News 25 Sep 2022

Solid Biosciences (NASDAQ:SLDB) & Aerie Pharmaceuticals ...

The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne...


WMC Market Score


WMC Market to Revenue Score


Ultragenyx Pharmaceutical Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Ultragenyx Pharmaceutical Inc. USD $334,116 $635,316 $-203,682 $31,230B 49
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Ultragenyx Pharmaceutical Inc. Social Followers vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. Post vs Top 4 Industry Competitors




Ultragenyx Pharmaceutical Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Ultragenyx Pharmaceutical Inc. 3.63 0 0 0 0 0 0.14
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries